Search results

109 results

• NEWSROOM

  Dr. Falk Pharma acquires Kynos Therapeutics

  ...adding acute pancreatitis as a therapeutic focus and further strengthening its development portfolio
• NEWSROOM

  Eating should be a pleasure

  What does it feel like to eat when you know that each bite will hurt when swallowing?
• Global presence & business partners

  Global presence & business partners Austria Dr. Falk Pharma Österreich GmbH Wolfgang-Pauli-Gasse 5 1140 Wien Phone: +43 1 577 35 16 0 Fax: +43 1 577 35 16 20 E-Mail: office@drfalkpharma.at Web:…
• NEWSROOM

  Completion of Enrollment of the Global Phase 2b Study

  ... Evaluating Naronapride in Gastroparesis (MOVE-IT)
• NEWSROOM

  Following the footsteps of our founder - The End

  Elena looks back and summarizes her journey: it's a collection of emotional encounters, funny moments, and, most of all, it's a big THANK YOU!
• NEWSROOM

  Today is World IBD Day 2025

  IBD Has No Borders – Breaking Taboos, Talking About It.
• NEWSROOM

  Positive results from pivotal phase 3 trial on norucholic acid in PSC

  The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam